Improved MHC II epitope prediction — a step towards personalized medicine

Numerous neoepitope-based vaccination strategies are in testing for clinical use in the treatment of cancer. Rapid identification of immunostimulatory neoantigen targets hastens neoantigen vaccine development. Papers recently published in Nature Biotechnology describe two independent machine-learnin...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Tamson V., Nishimura, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223749/
https://www.ncbi.nlm.nih.gov/pubmed/31836878
http://dx.doi.org/10.1038/s41571-019-0315-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223749/
https://www.ncbi.nlm.nih.gov/pubmed/31836878
http://dx.doi.org/10.1038/s41571-019-0315-0

Ejemplares similares